Biopharma Businesses

Telangana Aims to Emerge as India’s Life Sciences Innovation Capital with $25B Investment Target by 2030

Yuvraj — Tue, 18 Aug 2026 12:16:50 +0000

Strengthening Domestic API Depth and Reducing Import Reliance Key to Global Competitiveness Reaching $300B Valuation Demands Rapid Innovation, Biologics Scale, and Sustainable Quality Standards” True Advantage Beyond Cost: Innovation and Global Regulatory Excellence Must Drive India’s Next Pharma Phase” As India sets an ambitious roadmap to reach a USD 130 billion pharmaceutical market valuation by […]

The post Telangana Aims to Emerge as India’s Life Sciences Innovation Capital with $25B Investment Target by 2030 first appeared on World Pharma Today.

CPHI & PMEC Shenzhen 2026 Attracts Unprecedented International Interest as Demand for AI-Driven Innovation Grows

Yuvraj — Mon, 17 Aug 2026 11:53:51 +0000

CPHI & PMEC Shenzhen 2026 is set to welcome its most international audience to date, reflecting growing global interest in South China’s rapidly evolving pharmaceutical market and the technologies driving the next generation of healthcare innovation. Taking place from 16-18 September 2026 at the Shenzhen Convention & Exhibition Center (SZCEC), China, this year’s event is expected […]

The post CPHI & PMEC Shenzhen 2026 Attracts Unprecedented International Interest as Demand for AI-Driven Innovation Grows first appeared on World Pharma Today.

CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals

Yuvraj — Thu, 13 Aug 2026 06:49:27 +0000

CPHI has announced the launch of the CPHI Sustainability Summit, a new two-day event dedicated to advancing sustainability across the pharmaceutical value chain. Taking place at Fiera Milano, Italy, on 5-6 October 2026, alongside CPHI Milan, the summit will bring together more than 300 sustainability leaders, pharmaceutical executives and supply chain stakeholders to discuss practical action on one of […]

The post CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals first appeared on World Pharma Today.

Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets

Yuvraj — Thu, 09 Jul 2026 05:04:21 +0000

A new research project from the Johns Hopkins Bloomberg School of Public Health has identified a pharmaceutical industry practice that could be a significant factor in global health disparities. Published in PLOS Global Public Health on July 07, 2026, the study introduces and defines the concept of tiered manufacturing, which refers to the production of […]

The post Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets first appeared on World Pharma Today.

Sanofi Secures Global Rights to Rovadicitinib in $1.53B Deal

Yuvraj — Thu, 05 Mar 2026 12:12:13 +0000

Sanofi has committed up to $1.53 billion to obtain global rights to a novel therapy from Sino Biopharmaceutical, adding a first-in-class JAK/ROCK inhibitor to its hematology and immunology pipeline. The French pharmaceutical group will make an upfront payment of $135 million to Chia Tai Tianqing Pharmaceutical (CTTQ), a subsidiary of Sino Biopharm, to secure exclusive […]

The post Sanofi Secures Global Rights to Rovadicitinib in $1.53B Deal first appeared on World Pharma Today.

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

Yuvraj — Sat, 27 Dec 2025 08:51:16 +0000

AstraZeneca has gone ahead and committed $100 million to head deeper into the KRAS space by way of securing the right when it comes to a clinical-stage, multitarget asset from Jacobio Pharma of China. The U.K.-based pharma giant has scored the exclusive rights so as to develop and commercialize the pan-KRAS inhibitor, which is dubbed […]

The post AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio first appeared on World Pharma Today.

Bora – Corealis Collaborate for Oral Solid Dose Development

Yuvraj — Mon, 15 Dec 2025 08:57:47 +0000

Bora Pharmaceuticals Co. Ltd., which is a global leader when it comes to pharmaceutical manufacturing, along with a leading early-phase Contract Development Manufacturing Organization – CDMO, Corealis Pharma Inc., have gone on to enter into a strategic alliance so as to offer end-to-end services for oral solid dose development as well as manufacturing. The partnership […]

The post Bora – Corealis Collaborate for Oral Solid Dose Development first appeared on World Pharma Today.

Eli Lilly & IU Join Hands to Expand Clinical Trials Access

Yuvraj — Wed, 10 Dec 2025 08:22:49 +0000

A new agreement as per which Eli Lilly and Company is going to offer almost $40 million to Indiana University – IU has come to the fore. As Eli Lilly & IU join hands to expand access to clinical trials in Indiana, it gives patients a critical pathway to the latest investigational and innovative medicines […]

The post Eli Lilly & IU Join Hands to Expand Clinical Trials Access first appeared on World Pharma Today.

IQVIA Agentic AI Platform Builds New Capabilities with AWS

Yuvraj — Wed, 10 Dec 2025 07:47:59 +0000

IQVIA, known across the life sciences industry for its clinical research operations, commercial analytics, and health-data expertise, has entered a strategic collaboration with Amazon Web Services (AWS), naming AWS as its Preferred Agentic Cloud Provider. Announced during AWS re:Invent, the partnership supports the rollout of IQVIA’s next-generation agentic AI platform, which is intended to accelerate […]

The post IQVIA Agentic AI Platform Builds New Capabilities with AWS first appeared on World Pharma Today.

Trump To Exempt UK-Origin Pharmaceuticals from Tariffs

Yuvraj — Fri, 05 Dec 2025 07:27:41 +0000

The Trump administration has lined up yet another country-specific trade agreement, and this time it is going to be with the U.K., which confers the biggest break on pharmaceutical import tariffs yet with Washington. For its part, the U.K., which has indeed faced tough policy scrutiny from the biopharma industry in the recent months, is […]

The post Trump To Exempt UK-Origin Pharmaceuticals from Tariffs first appeared on World Pharma Today.